Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Russian Supplement Regulation Demands Careful Navigation

This article was originally published in The Tan Sheet

Executive Summary

In a guest commentary, Alexey Petrenko, a regulatory consultant in Eastern Europe, notes that Russia has emerged as a driver of growth in the global supplement market with double-digit compound annual growth over the past 10 years. But given the regulatory landscape, firms should be vigilant in staying abreast of how authorities are interpreting rules and where they are targeting their efforts.


Related Content

Valeant’s OTC Pickups Emphasize Specialty Segments, Growth Markets





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts